US Patent Issued to Kite Pharma, United States of America, as represented by the Secretary, Department of Health and Human Services on Nov. 4 for "Methods of conditioning patients for T cell therapy" (California, Maryland Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,654, issued on Nov. 4, was assigned to Kite Pharma Inc. (Santa Monica, Calif.) and United States of America, as represented by the Secretary, Department of Health and Human Services (Rockville, Md.).

"Methods of conditioning patients for T cell therapy" was invented by Adrian Bot (Santa Monica, Calif.), Jeffrey Wiezorek (Santa Monica, Calif.), William Go (Santa Monica, Calif.), Rajul Jain (Santa Monica, Calif.), James N. Kochenderfer (Bethesda, Md.) and Steven A. Rosenberg (Bethesda, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides methods of increasing the efficacy of a T cell therapy in a patient in need thereof. The invent...